Everpar Advisors LLC Acquires Shares of 7,444 Xylem Inc. (NYSE:XYL)

Everpar Advisors LLC acquired a new stake in Xylem Inc. (NYSE:XYL - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 7,444 shares of the industrial products company's stock, valued at approximately $851,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Simmons Bank boosted its position in Xylem by 2.1% in the 4th quarter. Simmons Bank now owns 12,345 shares of the industrial products company's stock valued at $1,412,000 after buying an additional 254 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Xylem by 3.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,284,264 shares of the industrial products company's stock valued at $146,868,000 after purchasing an additional 38,385 shares in the last quarter. Welch & Forbes LLC raised its stake in shares of Xylem by 450.1% in the 4th quarter. Welch & Forbes LLC now owns 53,133 shares of the industrial products company's stock valued at $6,076,000 after purchasing an additional 43,475 shares in the last quarter. Peregrine Asset Advisers Inc. acquired a new stake in shares of Xylem in the 4th quarter valued at about $400,000. Finally, Apollon Wealth Management LLC acquired a new stake in Xylem during the fourth quarter worth about $212,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, SVP Franz Cerwinka sold 2,408 shares of the firm's stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the transaction, the senior vice president now owns 11,750 shares of the company's stock, valued at approximately $1,431,032.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, SVP Franz Cerwinka sold 2,408 shares of the firm's stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the transaction, the senior vice president now owns 11,750 shares of the company's stock, valued at approximately $1,431,032.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm's stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the completion of the transaction, the chief accounting officer now directly owns 2,935 shares of the company's stock, valued at approximately $360,682.15. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by insiders.

Xylem Price Performance

NYSE:XYL traded up $0.83 during trading hours on Tuesday, reaching $140.03. 1,273,273 shares of the company's stock were exchanged, compared to its average volume of 1,186,048. The company has a market capitalization of $33.95 billion, a P/E ratio of 49.83, a price-to-earnings-growth ratio of 2.67 and a beta of 1.08. Xylem Inc. has a 12 month low of $87.59 and a 12 month high of $141.25. The company has a quick ratio of 1.22, a current ratio of 1.67 and a debt-to-equity ratio of 0.19. The business's 50-day simple moving average is $129.20 and its two-hundred day simple moving average is $116.21.

Xylem (NYSE:XYL - Get Free Report) last issued its earnings results on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share for the quarter, topping analysts' consensus estimates of $0.84 by $0.06. The firm had revenue of $2.03 billion during the quarter, compared to analysts' expectations of $2 billion. Xylem had a net margin of 8.34% and a return on equity of 8.95%. The firm's revenue for the quarter was up 40.4% compared to the same quarter last year. During the same period last year, the firm posted $0.72 earnings per share. Sell-side analysts expect that Xylem Inc. will post 4.24 EPS for the current fiscal year.

Analyst Ratings Changes

XYL has been the topic of several research reports. Mizuho increased their price objective on shares of Xylem from $110.00 to $135.00 and gave the stock a "neutral" rating in a research note on Friday. Oppenheimer raised their price target on shares of Xylem from $142.00 to $147.00 and gave the company an "outperform" rating in a research note on Friday. Royal Bank of Canada raised their price target on shares of Xylem from $157.00 to $162.00 and gave the company an "outperform" rating in a research note on Friday. Citigroup raised their price target on shares of Xylem from $126.00 to $139.00 and gave the company a "neutral" rating in a research note on Monday, April 8th. Finally, Robert W. Baird raised their price target on shares of Xylem from $151.00 to $155.00 and gave the company an "outperform" rating in a research note on Friday. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to data from MarketBeat.com, Xylem currently has an average rating of "Moderate Buy" and a consensus target price of $140.70.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.